Home / Recalls / MSN Laboratories Private Limited (Formulations Division, Unit-II) / D-0113-2027

D-0113-2027 Class II Ongoing

Recalled by MSN Laboratories Private Limited (Formulations Division, Unit-II) — Rangareddy District

FDA drug recall D-0113-2027 was initiated by MSN Laboratories Private Limited (Formulations Division, Unit-II) on Oct 21, 2026 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is ongoing. Affected quantity: 13,296 1,000-count bottles.

Recall details

Product Type: Drugs
Report Date: Nov 4, 2026
Initiation Date: Oct 21, 2026
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 13,296 1,000-count bottles

Product description

Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99

Reason for recall

Presence of Foreign Tablets/Capsules

Distribution pattern

Nationwide in the USA.

Code information

Lot: DRF09618A, Exp 08-31-2029, DRG02110A, Exp 01-31-2030.

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0113-2027
openFDA file date: Nov 10, 2026
Loaded by RegDataLab: Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.